Tilray Brands, Inc. (TLRY) stock remains unchanged at $1.42 as of the latest trading session. There is no specific news today explaining the stock's movement, or lack thereof.
On Reddit, discussions are centered around potential tariffs on Canadian Licensed Producers (LPs) and their impact on companies like Tilray. Users speculate that if these tariffs are implemented, they could increase costs for Canadian LPs, making it challenging to compete with U.S. producers. Some users suggest that smaller growers might not survive, potentially benefiting larger players like Tilray by reducing competition. Another topic of interest is the burgeoning market for hemp-derived THC beverages, which are expected to outpace regulated THC drinks. This market is projected to grow significantly, driven by millennials shifting from alcohol to cannabis drinks. Additionally, there is discussion about Denmark's move towards a permanent legal framework for medical cannabis, which could expand the market and potentially benefit companies like Tilray with operations in Europe. One user noted, "Aphria entered into a contract with Schroll when Denmark started their Trial program. Now that program has moved to Legal. Aphria had / has an opportunity to buy in up to 50%."
"Who's better set up globally than TLRY?"